![](/wp-content/uploads/2023/02/Screenshot-2023-02-03-at-3.21.46-PM.png)
$599
Sanofi and Regeneron Q4 ’22 Earnings Updates
Two cardiometabolic-related news items have been observed: Sanofi (press release; slides) and Regeneron (press release; slides) hosted their respective Q4 ’22 earnings calls. Below, FENIX provides highlights and insights from the earnings calls.